Hound Partners, founded in October 2004 by Jonathan Auerbach, a former senior analyst at Ziff Brothers Investments, is a New York-based hedge fund manager. The firm offers investment management services for global alternative long-only and long/short equity private investment funds, as well as separately managed accounts.
Jonathan Auerbach co-founded the long/short equity fund Hound Partners with Scott McLellan in 2004, backed by Tiger Management. Prior to this, Auerbach was a senior analyst at Ziff Brothers Investments and joined Tiger Management in 2004 to oversee a new umbrella fund, which evolved into Hound Partners. He holds an undergraduate degree from Princeton University (1996) and an MBA from Columbia Business School (2000).
Hound Partners manages discretionary assets totaling $4,271,542,989, as reported in their Form ADV dated March 2024, and serves 8 clients. Their latest 13F filing for Q1 2024 disclosed $335,488,562 in managed 13F securities, with a top 10 holdings concentration of 88.76%. The firm's largest holding is Bio-Rad Laboratories Inc. Class A, comprising 264,537 shares.
| Fund Name: | Hound Partners |
| Manager | Jonathan Auerbach |
| Portfolio Value | $504,265,932 |
| Change This QTR | +1.94% |
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | NVDA | 720,636 | $78,102,530 | +1809% | 15.49% | ||
| 2. | NCLH | 3,968,930 | $75,250,913 | NEW | 14.92% | ||
| 3. | CCL | 3,787,937 | $73,978,410 | NEW | 14.67% | ||
| 4. | EXPE | 422,797 | $71,072,176 | NEW | 14.09% | ||
| 5. | BIO BIOB | 201,783 | $49,146,267 | +243% | 9.75% |
| Symbol | Company | Filed By | Filing Date | Filing |
|---|---|---|---|---|
| 2023-02-14 | ||||
| 2023-02-14 | ||||
| 2023-02-14 | ||||
| 2022-03-31 | ||||
| 2022-02-17 |
